EnteroMedics

homesitemapcontact us

   search

 

   
 
 
   
   
 

Overview

 
 

About vBloc® Therapy

 
 

vBloc® Maestro® System

 
 

Obesity

 
 

Clinical Experience

 
 

     Obesity

 
 

     Diabetes

 

     Cardiovascular Disease

 
 

Publications

 
 

Clinical Experience in Diabetes

Type 2 diabetes is an escalating global health epidemic often related to obesity that affects nearly 200 million people worldwide. Type 2 diabetes is the most common type of diabetes, accounting for 90-95 percent of people with diabetes. Diabetes is the most common disorder of the endocrine (hormone) system and occurs when the body cannot regulate blood sugars. Those with diabetes are susceptible to cardiovascular morbidity and mortality, and up to two out of three people with diabetes have high blood pressure.

EnteroMedics® believes its proprietary VBLOC® vagal blocking therapy has the potential to be effective in the treatment of diabetes and hypertension associated with obesity. Literature suggests that vagal nerve signaling plays a key role in the control of blood glucose and blood pressure.

Learn more about our clinical trial results >.